Fredensborg, Denmark

Allan Jensen

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 89(Granted Patents)


Location History:

  • Fredensborg, DK (2010 - 2013)
  • Aberdeen, GB (2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Allan Jensen in Cancer Therapy

Introduction

Allan Jensen is a notable inventor based in Fredensborg, Denmark. He has made significant contributions to the field of cancer therapy through his innovative work on therapeutic antibodies. With a total of four patents to his name, Jensen's inventions are paving the way for new treatment options in oncology.

Latest Patents

Jensen's latest patents include groundbreaking inventions such as anti-HER2 antibodies and compositions. This invention relates to novel therapeutic antibodies directed against HER2 (ErbB2), as well as recombinant polyclonal anti-HER2 antibody compositions. These compositions comprise at least two of the recombinant anti-HER2 antibodies and are intended for the treatment of cancer. Another significant patent involves recombinant anti-epidermal growth factor receptor antibody compositions. This invention focuses on recombinant antibodies for use in human cancer therapy, providing compositions capable of binding human EGFR. Notably, antibody compositions with three or more antibodies have shown synergy in reducing the proliferation of representative cancer cell lines.

Career Highlights

Allan Jensen is currently associated with Symphogen A/S, where he continues to advance his research in therapeutic antibodies. His work has led to advantageous results, including a composition comprising two different chimeric anti-hEGFR antibodies. These antibodies demonstrate a new mechanism of action based on rapid and efficient receptor internalization, induction of terminal differentiation, and subsequent tumor eradication in animal models.

Collaborations

Jensen collaborates with esteemed colleagues such as Mikkel Wandahl Pedersen and Lucilla Steinaa. Their combined expertise contributes to the innovative research and development of antibody therapies.

Conclusion

Allan Jensen's contributions to the field of cancer therapy through his innovative patents highlight the potential of therapeutic antibodies in treating various cancers. His work continues to inspire advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…